CLIFinder: identification of LINE-1 chimeric transcripts in RNA-seq data
暂无分享,去创建一个
Romain Pogorelcnik | Philippe Arnaud | Marie-Elisa Pinson | Franck Court | Catherine Vaurs-Barrière | C. Vaurs-Barrière | Romain Pogorelcnik | F. Court | P. Arnaud | Marie-Elisa Pinson
[1] Peter A. Jones,et al. Hypomethylation of a LINE-1 Promoter Activates an Alternate Transcript of the MET Oncogene in Bladders with Cancer , 2010, PLoS genetics.
[2] Toby C. Cornish,et al. Genome-wide characterization of human L1 antisense promoter-driven transcripts , 2016, BMC Genomics.
[3] J. Vera-Otarola,et al. Activation of individual L1 retrotransposon instances is restricted to cell-type dependent permissive loci , 2016, eLife.
[4] J. L. Cortés,et al. Epigenetic Control of Retrotransposon Expression in Human Embryonic Stem Cells , 2010, Molecular and Cellular Biology.
[5] M. Speek,et al. L1 Antisense Promoter Drives Tissue-Specific Transcription of Human Genes , 2006, Journal of biomedicine & biotechnology.
[6] C. Tufarelli,et al. Isolation of cancer-specific chimeric transcripts induced by hypomethylation of the LINE-1 antisense promoter. , 2009, Genomics.
[7] M. Speek. Antisense Promoter of Human L1 Retrotransposon Drives Transcription of Adjacent Cellular Genes , 2001, Molecular and Cellular Biology.
[8] M. Speek,et al. Many human genes are transcribed from the antisense promoter of L1 retrotransposon. , 2002, Genomics.
[9] Stéphane Boissinot,et al. Molecular evolution and tempo of amplification of human LINE-1 retrotransposons since the origin of primates. , 2005, Genome research.
[10] Naveena Singh,et al. Neoadjuvant Chemotherapy Modulates the Immune Microenvironment in Metastases of Tubo-Ovarian High-Grade Serous Carcinoma , 2016, Clinical Cancer Research.